Agenda
Friday, October 29, 2010
| 7:15 | Registration & Continental Breakfast | ||||||||
| 7:55 | Welcome | ||||||||
| LAPAROENDOSCOPIC SINGLE SITE SURGERY Moderator: Dr. Kenneth Pace |
|||||||||
| 8:00 | Laparoendoscopic Single Site Surgery (LESS) and Natural Orifice Transluminal Endoscopic Surgery (NOTES) in 2010 – Dr. Jeffrey Cadeddu |
||||||||
| 8:40 | Lessons Learned from LESS: Minimizing the Morbidity of Laparoscopy – Dr. Kenneth Pace |
||||||||
| 8:50 | Discussion | ||||||||
| PROSTATE CANCER Moderator: Dr. Neil Fleshner |
|||||||||
| 9:00 | Update on Prostate Cancer Pathology – Dr. Marshall Scott Lucia | ||||||||
| 9:15 | Diet and Prostate Cancer Prevention – Dr. Vasu Venkateswaran | ||||||||
| 9:30 | Implications of the REDUCE Trial on Prevention and Screening – Dr. Gerald Andriole | ||||||||
| 10:00 | Break | ||||||||
| 10:30 | What should We Tell Patients about Prostate Cancer Prevention? Panel: Drs. N. Fleshner, G. Andriole, L. Klotz, V. Venkateswaran, A. Stephenson |
||||||||
| 11:15 | Screening: Lessons from USA-based Prostate, Lung, Colorectal and Ovary (PLCO) Cancer Trial, and the European Randomized Screening for Prostate Cancer (ERSPC) Trials – Dr. Andrew Stephenson |
||||||||
| 11:30 | Why I Refuse to have My PSA Done – Dr. Ian Tannock | ||||||||
| 11:45 | My Perspective – Dr. Gerald Andriole | ||||||||
| 12:00 | Lunch | ||||||||
| PROSTATE CANCER Moderator: Dr. Laurence Klotz |
|||||||||
| 1:00 |
|
||||||||
| 2:15 | Positive Margins and Prostate Cancer Survival – Dr. Marshall Scott Lucia | ||||||||
| 2:30 | Surgical Management of High-Risk Prostate Cancer – Dr. Misop Han | ||||||||
| 2:45 | Radiation Plus ADT for Locally Advanced Prostate Cancer – Dr. Padraig Warde | ||||||||
| 3:00 | Break | ||||||||
| PROSTATE CANCER Moderator: Dr. Michael Jewett |
|||||||||
| 3:30 | Discussion High-Risk Prostate Cancer | ||||||||
| 3:45 | Robotic Prostatectomy: The Next Chapter – Dr. Misop Han | ||||||||
| 4:00 | Should all Canadian Hospitals have a Robot? – Dr. John Trachtenberg | ||||||||
| 4:15 | Discussion | ||||||||
| 4:30 | ADT, Metabolic Syndrome, and Bone Health: What should Urologists Know? – Dr. Ian Tannock |
||||||||
| 4:45 | Discussion | ||||||||
| 5:00 | Adjourn | ||||||||
Saturday, October 30, 2010
| 7:15 | Registration & Continental Breakfast |
| ENDOUROLOGY Moderator: Dr. John Honey |
|
| 8:00 | Stratifying Stone Therapy: Shock, Scope, or Scalpel – Dr. Manoj Monga |
| 8:45 | Cases & Discussion – Drs. Manoj Monga & Kenneth Pace |
| RENAL CANCER Moderator: Dr. Antonio Finelli |
|
| 9:00 | The Importance of Renal Parenchyma Preservation: What are the Limits of Partial Nephrectomy? – Dr. Antonio Finelli |
| 9:15 | Is there a Role for Neoadjuvant or Adjuvant TKIs? – Dr. Georg Bjarnason |
| 9:30 | Metastatectomy in the TKI Era – Dr. Michael Jewett |
| 9:45 | Discussion |
| 10:00 | Break |
| ERECTILE DYSFUNCTION Moderator: Dr. Sid Radomski |
|
| 10:30 | Practical Approach to Investigation of ED and Sexual Dysfunction – Dr. Gerald Brock |
| 10:45 | Premature Ejaculation Update – Dr. Wayne Hellstrom |
| 11:05 | What’s New in Peyronie’s Disease? – Dr. Ethan Grober |
| 11:15 | Pearls on the Use of PDE5 Inhibitors – Dr. Gerald Brock |
| 11:35 | Current Management of Priapism – Dr. Wayne Hellstrom |
| 11:50 | Discussion & Cases |
| 12:10 | Lunch |
| ANTICOAGULATION IN UROLOGY | |
| 1:00 | Anticoagulation Prophylaxis in Urologic Surgery: What is the Evidence? – Dr. William Geerts |
| 1:30 | Discussion |
| OVERACTIVE BLADDER: PRIMARY & REFRACTORY Moderator: Dr. Sender Herschorn Vincent Colapinto Memorial Lecture |
|
| 1:45 | Pharmacotherapy of OAB – Dr. William Steers |
| 2:10 | Botulinum Toxin for Refractory OAB: What is the Evidence? – Dr. Sender Herschorn |
| 2:25 | Neuromodulation for Refractory OAB – Dr. Gamal Ghoniem |
| 2:40 | Panel Discussion: What to do with the Refractory OAB Patient |
| 3:00 | Break |
| FEMALE STRESS INCONTINENCE Moderator: Dr. Lesley Carr |
|
| 3:30 | The Value of Urodynamic Studies in the Work-up of SUI – Dr. William Steers |
| 3:45 | What’s New in Injectables? – Dr. Gamal Ghoniem |
| 4:00 | Which Mid-Urethral Sling is Best? – Dr. Sender Herschorn |
| 4:15 | Current Status of Stem Cell Therapy for SUI – Dr. Lesley Carr |
| 4:25 | Panel Discussion: Cases of Female SUI |
| 5:00 | Evaluation & Adjourn |
